Correlation Between BeiGene and Betta Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BeiGene and Betta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Betta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Betta Pharmaceuticals Co, you can compare the effects of market volatilities on BeiGene and Betta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Betta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Betta Pharmaceuticals.

Diversification Opportunities for BeiGene and Betta Pharmaceuticals

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between BeiGene and Betta is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Betta Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Betta Pharmaceuticals and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Betta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Betta Pharmaceuticals has no effect on the direction of BeiGene i.e., BeiGene and Betta Pharmaceuticals go up and down completely randomly.

Pair Corralation between BeiGene and Betta Pharmaceuticals

Assuming the 90 days trading horizon BeiGene is expected to under-perform the Betta Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, BeiGene is 1.44 times less risky than Betta Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Betta Pharmaceuticals Co is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  4,851  in Betta Pharmaceuticals Co on September 15, 2024 and sell it today you would earn a total of  617.00  from holding Betta Pharmaceuticals Co or generate 12.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

BeiGene  vs.  Betta Pharmaceuticals Co

 Performance 
       Timeline  
BeiGene 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BeiGene are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BeiGene may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Betta Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Betta Pharmaceuticals Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Betta Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

BeiGene and Betta Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BeiGene and Betta Pharmaceuticals

The main advantage of trading using opposite BeiGene and Betta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Betta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Betta Pharmaceuticals will offset losses from the drop in Betta Pharmaceuticals' long position.
The idea behind BeiGene and Betta Pharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators